Insulin Resistance and Polycystic Ovary Syndrome Through Life

Author(s): Evanthia Diamanti-Kandarakis, Poli Mara Spritzer, Teresa Sir-Petermann, Alicia Beatriz Motta

Journal Name: Current Pharmaceutical Design

Volume 18 , Issue 34 , 2012

Become EABM
Become Reviewer
Call for Editor


The heterogeneity of Polycystic Ovary Syndrome (PCOS) emphasizes the need for a consensual review of the data concerning its diagnosis and treatment and for determination of the relationship between the development of PCOS and the ethnic origin, the social status and the lifespan. Insulin resistance is an important characteristic in women with PCOS that aggravates features of PCOS. This review is focused in the diagnosis and treatment of insulin resistance and the risk factors for PCOS during childhood, adolescence and postmenopause. The role of endocrine disruptors and/or their interaction with PCOS have also been analyzed.

Keywords: Polycystic ovary syndrome, insulin resistance, child, adolescence, menopause, treatments, diagnosis, endocrine, risk factors, testosterone.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2012
Published on: 02 October, 2012
Page: [5569 - 5576]
Pages: 8
DOI: 10.2174/138161212803307590
Price: $65

Article Metrics

PDF: 23